Dr Paola Favuzza
Honorary (Fellow)
Department of Medical Biology (WEHI)
17 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
MK-7602: a potent multi-stage dual-targeting antimalarial
DOI: 10.1016/j.ebiom.2025.1060612025
Journal article
Translation of a Human-Based Malaria-on-a-Chip Phenotypic Disease Model for In Vivo Applications
DOI: 10.1002/advs.2025052062024
Journal article
The essential malaria protein PfCyRPA targets glycans to invade erythrocytes
DOI: 10.1016/j.celrep.2024.1140122023
Journal article
7-N-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome bc1 Complex
DOI: 10.1021/acsinfecdis.2c006072023
Journal article
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
DOI: 10.1021/acs.jmedchem.2c020922022
Journal article
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
DOI: 10.1021/acsmedchemlett.2c003552022
Journal article
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362
DOI: 10.1021/acs.jmedchem.2c01336
RECENT SCHOLARLY WORKS
2022
Journal article
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
DOI: 10.1002/cmdc.2022003062022
Journal article
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax
DOI: 10.1016/j.str.2022.03.0182021
Journal article
Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity
DOI: 10.1016/j.bioorg.2021.105359